Stereotaxis, Inc. (STXS)
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$1.390.00%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · STXS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 30.1 | 32.4 | 26.9 | 26.8 | 28.1 | 35.0 | 26.6 | 28.9 | 29.3 | 31.1 | 32.2 | 37.7 | 35.0 | 38.0 | 46.6 | 42.0 |
| Total Revenues | — | — | — | — | — | — | — | — | 29.3 | 31.1 | 32.2 | 37.7 | 35.0 | 38.0 | 46.6 | 42.0 |
| Cost of Revenues | 13.4 | 15.3 | 12.3 | 11.9 | 9.7 | 11.8 | 7.7 | 6.1 | 5.7 | 10.8 | 7.5 | 10.4 | 8.2 | 11.0 | 14.8 | 12.5 |
| Gross Profit | 16.7 | 17.1 | 14.6 | 14.9 | 18.5 | 23.2 | 19.0 | 22.8 | 23.6 | 20.4 | 24.6 | 27.2 | 26.8 | 27.0 | 31.8 | 29.5 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 10.0 | 9.4 | 9.8 | 10.3 | 10.6 | 10.2 | 8.1 | 9.0 | 8.2 | 6.7 | 5.5 | 6.3 | 5.2 | 5.7 | 8.4 | 12.9 |
| Operating Income | (22.8) | (22.1) | (24.7) | (21.8) | (18.8) | (12.9) | (6.7) | (4.8) | (2.5) | (5.9) | (6.4) | (5.4) | (5.4) | (8.8) | (10.6) | (31.9) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 0.0 | 0.2 | 2.5 | 3.3 | 3.3 | 12.6 | 6.9 | 3.5 |
| Interest & Investment Income | — | — | — | — | — | 0.1 | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | 2.5 | 3.3 | 3.3 | 12.6 | 6.9 | 3.5 |
| Asset Writedown | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | (22.3) | (21.6) | (24.0) | (20.7) | (18.3) | (10.7) | (6.6) | (4.6) | 0.1 | (5.9) | (5.3) | (7.4) | (5.2) | (68.8) | (9.2) | (32.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.22) | (0.25) | (0.30) | (0.27) | (0.26) | (0.16) | (0.11) | (0.10) | (0.03) | (0.32) | (0.54) | (0.35) | (0.26) | (5.95) | (1.33) | — |
| Diluted EPS | (0.22) | (0.25) | (0.30) | (0.27) | (0.26) | (0.16) | (0.11) | (0.10) | (0.03) | (0.32) | (0.54) | (0.35) | (0.26) | (5.95) | (1.33) | — |
| Revenue per Share | 0.30 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 100.0 | 91.0 | 85.2 | 80.7 | 76.1 | 75.6 | 72.7 | 63.1 | 52.1 | 22.6 | 21.8 | 21.1 | 19.9 | 11.6 | 6.9 | — |
| Diluted Weighted Avg Shares | 100.0 | 91.0 | 85.2 | 80.7 | 76.1 | 75.6 | 72.7 | 63.1 | 52.1 | 22.6 | 21.8 | 21.1 | 19.9 | 11.6 | 6.9 | — |
| Supplemental | ||||||||||||||||
| EBIT | (22.8) | (22.1) | (24.7) | (21.8) | (18.8) | (12.9) | (6.7) | (4.8) | (2.5) | (5.9) | (6.4) | (5.4) | (5.4) | (8.8) | (10.6) | (31.9) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.